Filing metadata

Accession number
0001062993-22-017410
Form type
Form 3
Filer
Kalaris Therapeutics, Inc.
CIK
CIK 1754068
Filed
Aug 05, 2022
Reporting period
Jul 28, 2022
Description
Initial ownership

Explore SEC Filings Hub